Skip to main content
Clinical Trials/ACTRN12621000627853
ACTRN12621000627853Not yet recruiting未知

Investigating the association between endometrial cystic spaces, endometrial hyperplasia and endometrial cancer in women with abnormal bleeding

The Royal Women's Hospital0 sites792 target enrollmentStarted: May 25, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
792

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
30 Years to o limit (—)
Sex
Female

Inclusion Criteria

  • Women aged 30 years old and above
  • With abnormal uterine bleeding
  • o Defined by any of the following: Postmenopausal bleeding
  • Intermenstrual bleeding
  • Postcoital bleeding with a normal cervical screening test (CST) Bleeding less than every 22 days
  • Heavy or prolonged bleeding
  • And waitlisted for HDC or endometrial biopsy for investigation of abnormal uterine bleeding

Exclusion Criteria

  • Inability to consent: no capacity or does not fully comprehend consent information
  • Known current or previous history of endometrial hyperplasia or endometrial cancer
  • Endometrial sampling or intrauterine manipulation performed less than 28 days prior to
  • recruitment (due to potential alteration of endometrium and impact on subsequent ultrasound
  • Non english speaking background

Investigators

Sponsor
The Royal Women's Hospital

Similar Trials

The association between endometrial cystic... | Clinical Trial